Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-01-03 @ 8:15 PM
Study NCT ID:
NCT02511795
Status:
COMPLETED
Last Update Posted:
2019-11-07
First Post:
2015-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-23
First Submit QC Date:
None
Study First Post Date:
2015-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-07
Last Update Post Date Type:
ACTUAL